Haemonetics Corp (HAE)

R&D Expense Growth

-13.91%

Fiscal year · Period ending:

HAE logo

HAE R&D Expense Growth

Latest reported-13.91%
HAE FY R&D Growth (YoY) (0.00% → -13.91%)
High-resolution chart · PNG

HAE r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Haemonetics Corp R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-13.9091%
10.1325%
7.5114%
6.2137%
35.7724%
4.0273%
9.4333%
-8.9579%
-16.9883%
-15.4104%
3.0967%
-0.024%
11.4286%
32.173%
12.6929%
23.8095%
10.5495%
-1.9036%
1.8339%
-9.9261%
32.6198%
12.37%
-8.81%
0%
2.4844%
27.5474%
-1.1457%
-15.6425%
-5.7895%
2.7027%
10.7784%
5.6962%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.